María Fe Muñoz-Moreno

María Fe Muñoz-Moreno

Auto-generated profile, based on publicly available information

María Fe Muñoz-Moreno

Hospital Clínico Universitario de Valladolid, Valladolid, Spain

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
OVOlga de la Varga-Martínez
Olga de la Varga-Martínez
RGRocío Gutiérrez-Bustillo
Rocío Gutiérrez-Bustillo
MMMaría Fe Muñoz-Moreno
María Fe Muñoz-Moreno
RLRocío López-Herrero Rocío López-Herrero
Rocío López-Herrero Rocío López-Herrero
EGEsther Gómez-Sánchez
Esther Gómez-Sánchez
ETEduardo Tamayo
Eduardo Tamayo

Verified
Journal Article
Open access
PDF file
AVAlvaro Tamayo Velasco
Alvaro Tamayo Velasco
PMPedro Martínez-Paz
Pedro Martínez-Paz
MPMaría Jesús Peñarrubia-Ponce
María Jesús Peñarrubia-Ponce
IGIGNACIO DE LA FUENTE GRACIANI
IGNACIO DE LA FUENTE GRACIANI
SGSonia Perez Gonzalez
Sonia Perez Gonzalez
HGHugo Gonzalo
Hugo Gonzalo
Pneumonia is the leading cause of hospital admission and mortality in coronavirus disease 2019 (COVID-19). We aimed to identify the cytokines responsible for lung damage and mortality. We prospectively recruited 108 COVID-19 patients between March and April 2020 and divided them into four groups according to the severity of respiratory symptoms. Twenty-eight healthy volunteers were used for normalization of the results. Multiple cytokines showed statistically significant differences between mild and critical patients. High HGF levels were associated with the critical group (OR = 3.51; p < 0.001; 95%CI = 1.95–6.33). Moreover, high IL-1α (OR = 1.36; p = 0.01; 95%CI = 1.07–1.73) and low IL-27 (OR = 0.58; p < 0.005; 95%CI = 0.39–0.85) greatly increased the risk of ending up in the severe group. This model was especially sensitive in order to predict critical status (AUC = 0.794; specificity = 69.74%; sensitivity = 81.25%). Furthermore, high levels of HGF and IL-1α showed significant results in the survival analysis (p = 0.033 and p = 0.011, respectively). HGF, IL-1α, and IL 27 at hospital admission were strongly associated with severe/critical COVID-19 patients and therefore are excellent predictors of bad prognosis. HGF and IL-1α were also mortality biomarkers.

22 October 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Christian Ortega LoubonChristian Ortega Loubon
Christian Ortega Loubon
MMMaría Fe Muñoz-Moreno
María Fe Muñoz-Moreno
IGIrene Andrés García
Irene Andrés García
F. JAVIER ALVAREZF. JAVIER ALVAREZ
F. JAVIER ALVAREZ
EGEsther Gómez-Sánchez
Esther Gómez-Sánchez
MHMaría Heredia-Rodríguez
María Heredia-Rodríguez
Major changes have occurred in the epidemiology and etiology of infective endocarditis (IE). Nevertheless, the differences between nosocomial infective endocarditis (NIE) and community-acquired infective endocarditis (CIE) have not been addressed in a population-based study. We conducted a retrospective, nationwide, temporal trend study from 1997 to 2014 analyzing the epidemiology, clinical, geographical, meteorological characteristics of patients diagnosed with IE in Spain, to distinguish NIE from CIE. Among 25,952 patients with IE (62.2 ± 18·6 years; 65.9% men), 45.9% had NIE. The incidence of IE increased from 2.83 to 3.73 due to the NIE incidence increment with a decline in CIE. Patients with NIE were older (63.8 years vs. 60.8 years, p < 0·001), presented a higher Charlson index (1.22 vs. 1.03, p < 0.001), a greater history of implanted cardiac devices (8.7% vs. 4.6%, p < 0.001), and higher mortality (31.5% vs. 21.7%, p < 0.001). The most frequent microorganism for both NIE and CIE was Staphylococcus (p < 0.001), and the North reported a higher incidence (p < 0.001). Risk factors of mortality for NIE were age, Charlson index, hemodialysis, shock, heart failure, and stroke. Risk factors for CIE included female sex, renal disease, and cardiac-device carriers. The etiology of IE shifted from community origins to mostly nosocomial-associated infections. Higher morbidity, mortality, and poorer outcomes are associated with NIE.

20 September 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Christian Ortega LoubonChristian Ortega Loubon
Christian Ortega Loubon
BCBeatriz Cano-Hernández
Beatriz Cano-Hernández
RPRodrigo Poves-Álvarez
Rodrigo Poves-Álvarez
MMMaría Fe Muñoz-Moreno
María Fe Muñoz-Moreno
PRPatricia Román-García
Patricia Román-García
MHMaría Heredia-Rodríguez
María Heredia-Rodríguez
Lymphopenia has been related to increased mortality in septic patients. Nonetheless, the impact of lymphocyte count on candidemia mortality and prognosis has not been addressed. We conducted a retrospective study, including all admitted patients with candidemia from 2007 to 2016. We examined lymphocyte counts during the first 5 days following the diagnosis of candidemia. Multivariable logistic regression analysis was performed to determine the relationship between lymphocyte count and mortality. Classification and Regression Tree analysis was used to identify the best cut-off of lymphocyte count for mortality associated with candidemia. From 296 cases of candidemia, 115 died, (39.8% 30-day mortality). Low lymphocyte count was related to mortality and poor outcome (p < 0.001). Lymphocyte counts <0.703 × 109 cells/L at diagnosis (area under the curve (AUC)-ROC, 0.783 ± 0.042; 95% confidence interval (CI), 0.700–0.867, p < 0.001), and lymphocyte count <1.272 × 109 cells/L five days later (AUC-ROC, 0.791 ± 0.038; 95%CI, 0.716–0.866, p < 0.001) increased the odds of mortality five-fold (odds ratio (OR), 5.01; 95%CI, 2.39–10.93) at time of diagnosis, and three-fold (OR, 3.27; 95%CI, 1.24–8.62) by day 5, respectively. Low lymphocyte count is an independent predictor of mortality in patients with candidemia and might serve as a biomarker for predicting candidemia-associated mortality and poor outcome.

Verified
Journal Article
Open access
PDF file
ESElena Carrasco Serrano
Elena Carrasco Serrano
PJPablo Jorge-Monjas
Pablo Jorge-Monjas
MMMaría Fé Muñoz-Moreno
María Fé Muñoz-Moreno
EGEsther Gómez-Sánchez
Esther Gómez-Sánchez
JPJuan Manuel Priede-Vimbela
Juan Manuel Priede-Vimbela
Christian Ortega LoubonChristian Ortega Loubon
Christian Ortega Loubon
One of the strongest risk factors for death in individuals undergoing cardiac surgery is Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI). Although the minimum kidney oxygen delivery index (DO2i) during cardiopulmonary bypass (CPB) has been reported, the optimal threshold value has not yet been established. A prospective study was conducted from June 2012 to January 2016 to asses how DO2i influences the pathogenesis of CSA-AKI, as well as its most favorable cut-off value. DO2 levels were recorded at the beginning, middle, and end of the CPB. The association between DO2i and CSA-AKI was investigated using multivariable logistic regression analysis. The optimal cut-off of DO2i as a predictor of CSA-AKI was determined using Classification and Regression Tree (CART) analysis. A total of 782 consecutive patients were enrolled. Of these, 231 (29.5%) patients developed AKI. Optimal DO2i thresholds of 303 mL/min/m2 during the CPB and 295 mL/min/m2 at the end of the intervention were identified, which increased the odds of CSA-AKI almost two-fold (Odds Ratio (OR), 1.90; 95% CI, 1.12–3.24) during the surgery and maintained that risk (OR 1.94; 95% CI, 1.15–3.29) until the end. Low DO2i during cardiopulmonary bypass is a risk factor for CSA-AKI that cannot be ruled out. Continuous renal oxygen supply monitoring for adult patients could be a promising method for predicting AKI during CPB.

4 August 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MMMaria Fe Muñoz-Moreno
Maria Fe Muñoz-Moreno
PRPablo Ryan
Pablo Ryan
AMAlejandro Alvaro Meca
Alejandro Alvaro Meca
JVJorge Valencia
Jorge Valencia
ETEduardo Tamayo
Eduardo Tamayo
SRSalvador Resino
Salvador Resino
Background: People living with human immunodeficiency virus (HIV) (PLWH) form a vulnerable population for the onset of infective endocarditis (IE). We aimed to analyze the epidemiological trend of IE, as well as its microbiological characteristics, in PLWH during the combined antiretroviral therapy era in Spain. Methods: We performed a retrospective study (1997–2014) in PLWH with data obtained from the Spanish Minimum Basic Data Set. We selected 1800 hospital admissions with an IE diagnosis, which corresponded to 1439 patients. Results: We found significant downward trends in the periods 1997–1999 and 2008–2014 in the rate of hospital admissions with an IE diagnosis (from 21.8 to 3.8 events per 10,000 patients/year; p < 0.001), IE incidence (from 18.2 to 2.9 events per 10,000 patients/year; p < 0.001), and IE mortality (from 23.9 to 5.5 deaths per 100,000 patient-years; p < 0.001). The most frequent microorganisms involved were staphylococci (50%; 42.7% Staphylococcus aureus and 7.3% coagulase-negative staphylococci (CoNS)), followed by streptococci (9.3%), Gram-negative bacilli (8.3%), enterococci (3%), and fungus (1.4%). During the study period, we found a downward trend in the rates of CoNS (p < 0.001) and an upward trends in streptococci (p = 0.001), Gram-negative bacilli (p < 0.001), enterococci (p = 0.003), and fungus (p < 0.001) related to IE, mainly in 2008–2014. The rate of community-acquired IE showed a significant upward trend (p = 0.001), while the rate of health care-associated IE showed a significant downward trend (p < 0.001). Conclusions: The rates of hospital admissions, incidence, and mortality related to IE diagnosis in PLWH in Spain decreased from 1997 to 2014, while other changes in clinical characteristics, mode of acquisition, and pathogens occurred over this time.